---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-018937"
form_type: "8-K"
ticker: "AUPH"
cik: "0001600620"
company_name: "Aurinia Pharmaceuticals Inc."
filed_at: "2022-07-15T23:59:59+00:00"
generated_at: "2026-06-24T14:06:58.666830+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Aurinia and CCO Max Colao mutually agree to separation effective July 22

## Summary
- Max Colao, Chief Commercial Officer, will cease employment on July 22, 2022 by mutual agreement.
- Severance includes 12 months base salary ($488,835) plus eligibility for performance bonus (target $244,418).
- COBRA benefits for up to 12 months if elected.
- No replacement named; separation agreement expected to mirror existing employment terms.

## SEC filing metadata
- accession: 0001628280-22-018937
- form_type: 8-K
- ticker: AUPH
- cik: 0001600620
- company_name: Aurinia Pharmaceuticals Inc.
- filed_at: 2022-07-15T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1600620/000162828022018937/0001628280-22-018937-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1600620/000162828022018937/auph-20220715.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-018937
- JSON: https://secwatch.observer/filing/0001628280-22-018937.json
- Plain text: https://secwatch.observer/filing/0001628280-22-018937.txt

## Key facts
- Executive change
  Max Colao departed as Chief Commercial Officer at Aurinia Pharmaceuticals Inc..
  - Action: mutually agreed to cease employment
  - Role: Chief Commercial Officer
  source text: On July 11, 2022, Aurinia Pharmaceuticals Inc. and Max Colao, our Chief Commercial Officer, mutually agreed that Mr. Colao would cease his employment with Aurinia, effective July 22, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1600620/000162828022018937/0001628280-22-018937-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.